[1] D′Ambrosio R,Aghemo A. Treatment of patients with HCV related cirhosis:many rewards with very fewrisks. Hepat Mon,2012,12:361-368. [2] 蒋音. 肝穿刺对鉴别自身免疫性肝炎与DILI的价值. 肝脏,2012,17(1):47. [3] 中华医学会消化病学分会肝胆疾病协作组. 药物性肝损伤诊治建议(草案). 中华消化杂志,2007,27(11):765-767. [4] Schiff E,Sorrell M,Maddrew W.Schiffs disease of the liver. 8ed, Philadelphia:Lippincott Raven,1999:919-926. [5] Zhang Y,Wang B,Wang T.De novo autoimmune hepatitis with centrilobular necrosis following liver transplantion for primary biliary cirrhosis:a case report. Transplant Proc,2010,42(9):3854-3857. [6] Maillette de Buy WL,Beuers U. Bile salts and cholestasis. Dig Liver Dis,2010,42(6):409-418. [7] 何艳. 药物诱导的自身免疫性肝炎研究进展. 实用肝脏病杂志,2013,16(2):178-180. [8] Appleyard S,Saraswati R,Gorard DA.Autoimmune hepatitis triggered by nitrofurantoin:a case series. J Med Case Rep,2010,4:311. [9] 姚云洁,刘鸿凌,朱冰,等. 441例DILI患者临床何肝组织病理学分析. 实用肝脏病杂志,2015,18(3):286-289. |